Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Progesterone receptor (PR) mediates the actions of the ovarian steroid progesterone, which
together with estradiol regulates gonadotropin secretion, prepares the endometrium for …
together with estradiol regulates gonadotropin secretion, prepares the endometrium for …
Endometrial cancer
F Amant, P Moerman, P Neven, D Timmerman… - The Lancet, 2005 - thelancet.com
Each year, endometrial cancer develops in about 142 000 women worldwide, and an
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
estimated 42 000 women die from this cancer. The typical age-incidence curve for …
Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review
OBJECTIVE: The objective of this review was to analyze published contemporary oncologic
and reproductive outcomes in women with endometrial hyperplasia or cancer undergoing …
and reproductive outcomes in women with endometrial hyperplasia or cancer undergoing …
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and …
OBJECTIVE: The objective of the study was to evaluate the regression, relapse, and live
birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) …
birth rates of early-stage endometrial cancer (EC) and atypical complex hyperplasia (ACH) …
[HTML][HTML] Theories of endometrial carcinogenesis: a multidisciplinary approach
ME Sherman - Modern Pathology, 2000 - Elsevier
Historical observations have suggested that endometrial carcinomas vary in histopathologic
appearance and clinical features. More recent, systematic studies have provided …
appearance and clinical features. More recent, systematic studies have provided …
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
K Ushijima, H Yahata, H Yoshikawa… - Journal of clinical …, 2007 - ascopubs.org
Purpose To assess the efficacy of fertility-sparing treatment using medroxyprogesterone
acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in …
acetate (MPA) for endometrial carcinoma (EC) and atypical endometrial hyperplasia (AH) in …
The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: Evidence of distinct molecular genetic …
SF Lax, B Kendall, H Tashiro, RJC Slebos… - Cancer, 2000 - Wiley Online Library
BACKGROUND The two most common types of uterine endometrial carcinoma,
endometrioid (UEC) and serous (USC), differ in their histopathologic appearance and …
endometrioid (UEC) and serous (USC), differ in their histopathologic appearance and …
Endometrial cancer: not your grandmother's cancer
JN McAlpine, SM Temkin, HJ Mackay - Cancer, 2016 - Wiley Online Library
Worldwide, the incidence of endometrial carcinoma (EC) is rapidly increasing, and the
highest disease burden is reported in North America and Western Europe. Although the …
highest disease burden is reported in North America and Western Europe. Although the …
[HTML][HTML] Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma …
Objective To evaluate the various possible prognostic factors on the fertility-sparing
management of atypical hyperplasia and endometrial cancer; to generate survival curves to …
management of atypical hyperplasia and endometrial cancer; to generate survival curves to …
[HTML][HTML] Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
TC Randall, RJ Kurman - Obstetrics & Gynecology, 1997 - Elsevier
Objective: To determine the efficacy of conservative management of atypical hyperplasia
and well-differentiated carcinoma of the endometrium in women under age 40. Methods …
and well-differentiated carcinoma of the endometrium in women under age 40. Methods …